Appendix 2A - Application for quotation of securities Announcement Summary Entity name RECCE PHARMACEUTICALS LTD Announcement Type New announcement Date of this announcement Monday November 16, 2026 The +securities to be quoted are: Other Please refer to the response to Q2.3d for further...
Application for quotation of securities - RCE
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Recce Pharmaceuticals Ltd. has filed an application for the quotation of securities on the ASX, specifically for fully paid ordinary shares. The application includes the issuance of shares as part payment for legal services provided to the company. The filing confirms that these securities will rank equally with existing shares in the same class.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Notification regarding unquoted securities - RCE
- Final Director's Interest Notice - Mr McKeough
- Results of Meeting
- AGM Presentation
- Retirement of Mr Alistair McKeough as Non-Executive Director
Later from Recce Pharmaceuticals
All Recce Pharmaceuticals news releasesFollow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals